PTPRC and neoplasm: Segmentation based on cell type markers within a region of interest (ROI) in each tissue specimen was used to demarcate areas enriched with immune cells (CD45+), tumor cells (Pan-CK+ or morphologically tumor cells in H&E staining of serial section lacking positivity of the cell type markers), and stroma (SMA+) (Supplementary Fig. 3).